$HSGX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Ocugen, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Ocugen, Inc.. Get notifications about new insider transactions in Ocugen, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 01 2021 | HSGX | Ocugen, Inc. | Kompella Uday | Director | Option Exercise | M | 1.88 | 7,191 | 13,519 | 0 | |
Jun 01 2021 | HSGX | Ocugen, Inc. | Kompella Uday | Director | Sell | S | 8.82 | 7,191 | 63,417 | 550,674 | 557.9 K to 550.7 K (-1.29 %) |
Jun 01 2021 | HSGX | Ocugen, Inc. | Kompella Uday | Director | Buy | M | 1.88 | 7,191 | 13,519 | 557,865 | 550.7 K to 557.9 K (+1.31 %) |
May 14 2021 | HSGX | Ocugen, Inc. | Subramanian Sanjay | Chief Financial Off ... | Option Exercise | M | 0.34 | 31,000 | 10,540 | 338,256 | |
May 14 2021 | HSGX | Ocugen, Inc. | Subramanian Sanjay | Chief Financial Off ... | Sell | S | 8.18 | 31,000 | 253,673 | 45,591 | 76.6 K to 45.6 K (-40.47 %) |
May 14 2021 | HSGX | Ocugen, Inc. | Subramanian Sanjay | Chief Financial Off ... | Buy | M | 0.34 | 31,000 | 10,540 | 76,591 | 45.6 K to 76.6 K (+68.00 %) |
May 05 2021 | HSGX | Ocugen, Inc. | Tammara Vijay | Senior Vice Preside ... | Option Exercise | M | 0.57 | 2,311 | 1,306 | 42,578 | |
May 05 2021 | HSGX | Ocugen, Inc. | Tammara Vijay | Senior Vice Preside ... | Option Exercise | M | 0.51 | 6,500 | 3,315 | 58,261 | |
May 05 2021 | HSGX | Ocugen, Inc. | Tammara Vijay | Senior Vice Preside ... | Option Exercise | M | 2.94 | 2,000 | 5,880 | 2,191 | |
May 05 2021 | HSGX | Ocugen, Inc. | Tammara Vijay | Senior Vice Preside ... | Option Exercise | M | 0.46 | 4,900 | 2,254 | 0 | |
May 05 2021 | HSGX | Ocugen, Inc. | Tammara Vijay | Senior Vice Preside ... | Sell | S | 13.81 | 2,311 | 31,915 | 0 | 2.3 K to 0 (-100.00 %) |
May 05 2021 | HSGX | Ocugen, Inc. | Tammara Vijay | Senior Vice Preside ... | Buy | M | 0.57 | 2,311 | 1,306 | 2,311 | 0 to 2.3 K |
May 05 2021 | HSGX | Ocugen, Inc. | Tammara Vijay | Senior Vice Preside ... | Sell | S | 13.50 | 6,500 | 87,750 | 0 | 6.5 K to 0 (-100.00 %) |
May 05 2021 | HSGX | Ocugen, Inc. | Tammara Vijay | Senior Vice Preside ... | Buy | M | 0.51 | 6,500 | 3,315 | 6,500 | 0 to 6.5 K |
May 05 2021 | HSGX | Ocugen, Inc. | Tammara Vijay | Senior Vice Preside ... | Sell | S | 13.81 | 2,000 | 27,620 | 0 | 2 K to 0 (-100.00 %) |
May 05 2021 | HSGX | Ocugen, Inc. | Tammara Vijay | Senior Vice Preside ... | Buy | M | 2.94 | 2,000 | 5,880 | 2,000 | 0 to 2 K |
May 05 2021 | HSGX | Ocugen, Inc. | Tammara Vijay | Senior Vice Preside ... | Sell | S | 13.81 | 4,900 | 67,669 | 0 | 4.9 K to 0 (-100.00 %) |
May 05 2021 | HSGX | Ocugen, Inc. | Tammara Vijay | Senior Vice Preside ... | Buy | M | 0.46 | 4,900 | 2,254 | 4,900 | 0 to 4.9 K |
May 05 2021 | HSGX | Ocugen, Inc. | Potti Manish | Director | Sell | S | 15.02 | 60,000 | 901,200 | 63,429 | 123.4 K to 63.4 K (-48.61 %) |
May 05 2021 | HSGX | Ocugen, Inc. | Potti Manish | Director | Sell | S | 15.01 | 28,000 | 420,280 | 0 | 28 K to 0 (-100.00 %) |
May 03 2021 | HSGX | Ocugen, Inc. | Subramanian Sanjay | Chief Financial Off ... | Option Exercise | M | 2.19 | 7,990 | 17,498 | 15,980 | |
May 03 2021 | HSGX | Ocugen, Inc. | Subramanian Sanjay | Chief Financial Off ... | Sell | S | 10.98 | 7,990 | 87,730 | 45,591 | 53.6 K to 45.6 K (-14.91 %) |
May 03 2021 | HSGX | Ocugen, Inc. | Subramanian Sanjay | Chief Financial Off ... | Buy | M | 2.19 | 7,990 | 17,498 | 53,581 | 45.6 K to 53.6 K (+17.53 %) |
May 03 2021 | HSGX | Ocugen, Inc. | Kompella Uday | Director | Option Exercise | M | 0.51 | 20,000 | 10,200 | 34,000 | |
May 03 2021 | HSGX | Ocugen, Inc. | Kompella Uday | Director | Sell | S | 16.02 | 25,000 | 400,500 | 550,674 | 575.7 K to 550.7 K (-4.34 %) |
May 03 2021 | HSGX | Ocugen, Inc. | Kompella Uday | Director | Sell | S | 14.00 | 25,000 | 350,000 | 575,674 | 600.7 K to 575.7 K (-4.16 %) |
May 03 2021 | HSGX | Ocugen, Inc. | Kompella Uday | Director | Sell | S | 11.56 | 20,000 | 231,200 | 600,674 | 620.7 K to 600.7 K (-3.22 %) |
May 03 2021 | HSGX | Ocugen, Inc. | Kompella Uday | Director | Buy | M | 0.51 | 20,000 | 10,200 | 620,674 | 600.7 K to 620.7 K (+3.33 %) |
May 03 2021 | HSGX | Ocugen, Inc. | Musunuri Shankar | Chief Executive Off ... | Option Exercise | M | 0.51 | 195,809 | 99,863 | 737,719 | |
May 03 2021 | HSGX | Ocugen, Inc. | Musunuri Shankar | Chief Executive Off ... | Sell | S | 14.24 | 195,809 | 2,788,320 | 406,000 | 601.8 K to 406 K (-32.54 %) |
May 03 2021 | HSGX | Ocugen, Inc. | Musunuri Shankar | Chief Executive Off ... | Buy | M | 0.51 | 195,809 | 99,863 | 601,809 | 406 K to 601.8 K (+48.23 %) |
May 03 2021 | HSGX | Ocugen, Inc. | Tammara Vijay | Senior Vice Preside ... | Option Exercise | M | 0.46 | 4,317 | 1,986 | 4,900 | |
May 03 2021 | HSGX | Ocugen, Inc. | Tammara Vijay | Senior Vice Preside ... | Option Exercise | M | 0.57 | 5,111 | 2,913 | 44,889 | |
May 03 2021 | HSGX | Ocugen, Inc. | Tammara Vijay | Senior Vice Preside ... | Option Exercise | M | 0.51 | 12,880 | 6,569 | 64,761 | |
May 03 2021 | HSGX | Ocugen, Inc. | Tammara Vijay | Senior Vice Preside ... | Option Exercise | M | 2.94 | 3,000 | 8,820 | 4,191 | |
May 03 2021 | HSGX | Ocugen, Inc. | Tammara Vijay | Senior Vice Preside ... | Option Exercise | M | 0.46 | 9,000 | 4,140 | 9,217 | |
May 03 2021 | HSGX | Ocugen, Inc. | Tammara Vijay | Senior Vice Preside ... | Sell | S | 16.00 | 4,317 | 69,072 | 0 | 4.3 K to 0 (-100.00 %) |
May 03 2021 | HSGX | Ocugen, Inc. | Tammara Vijay | Senior Vice Preside ... | Buy | M | 0.46 | 4,317 | 1,986 | 4,317 | 0 to 4.3 K |
May 03 2021 | HSGX | Ocugen, Inc. | Tammara Vijay | Senior Vice Preside ... | Sell | S | 10.96 | 5,111 | 56,017 | 0 | 5.1 K to 0 (-100.00 %) |
May 03 2021 | HSGX | Ocugen, Inc. | Tammara Vijay | Senior Vice Preside ... | Buy | M | 0.57 | 5,111 | 2,913 | 5,111 | 0 to 5.1 K |
May 03 2021 | HSGX | Ocugen, Inc. | Tammara Vijay | Senior Vice Preside ... | Sell | S | 10.96 | 12,880 | 141,165 | 0 | 12.9 K to 0 (-100.00 %) |
May 03 2021 | HSGX | Ocugen, Inc. | Tammara Vijay | Senior Vice Preside ... | Buy | M | 0.51 | 12,880 | 6,569 | 12,880 | 0 to 12.9 K |
May 03 2021 | HSGX | Ocugen, Inc. | Tammara Vijay | Senior Vice Preside ... | Sell | S | 10.99 | 3,000 | 32,970 | 0 | 3 K to 0 (-100.00 %) |
May 03 2021 | HSGX | Ocugen, Inc. | Tammara Vijay | Senior Vice Preside ... | Buy | M | 2.94 | 3,000 | 8,820 | 3,000 | 0 to 3 K |
May 03 2021 | HSGX | Ocugen, Inc. | Tammara Vijay | Senior Vice Preside ... | Sell | S | 10.97 | 9,000 | 98,730 | 0 | 9 K to 0 (-100.00 %) |
May 03 2021 | HSGX | Ocugen, Inc. | Tammara Vijay | Senior Vice Preside ... | Buy | M | 0.46 | 9,000 | 4,140 | 9,000 | 0 to 9 K |
Apr 28 2021 | HSGX | Ocugen, Inc. | Kompella Uday | Director | Sell | S | 11.70 | 350,000 | 4,095,000 | 600,674 | 950.7 K to 600.7 K (-36.82 %) |
Apr 21 2021 | HSGX | Ocugen, Inc. | Kumar Ramesh | Director | Option Exercise | M | 0.51 | 7,500 | 3,825 | 46,500 | |
Apr 21 2021 | HSGX | Ocugen, Inc. | Kumar Ramesh | Director | Sell | S | 5.33 | 7,500 | 39,975 | 0 | 7.5 K to 0 (-100.00 %) |
Apr 21 2021 | HSGX | Ocugen, Inc. | Kumar Ramesh | Director | Buy | M | 0.51 | 7,500 | 3,825 | 7,500 | 0 to 7.5 K |
Mar 08 2021 | HSGX | Ocugen, Inc. | Potti Manish | Director | Option Exercise | M | 1.83 | 7,000 | 12,810 | 119,000 | |
Mar 08 2021 | HSGX | Ocugen, Inc. | Potti Manish | Director | Option Exercise | M | 0.51 | 21,000 | 10,710 | 33,000 | |
Mar 08 2021 | HSGX | Ocugen, Inc. | Potti Manish | Director | Buy | M | 1.83 | 7,000 | 12,810 | 28,000 | 21 K to 28 K (+33.33 %) |
Mar 08 2021 | HSGX | Ocugen, Inc. | Potti Manish | Director | Buy | M | 0.51 | 21,000 | 10,710 | 21,000 | 0 to 21 K |
Feb 01 2021 | HSGX | Ocugen, Inc. | Subramanian Sanjay | Chief Financial Off ... | Option Exercise | M | 0.51 | 35,591 | 18,151 | 71,183 | |
Feb 01 2021 | HSGX | Ocugen, Inc. | Subramanian Sanjay | Chief Financial Off ... | Buy | M | 0.51 | 35,591 | 18,151 | 45,591 | 10 K to 45.6 K (+355.91 %) |
Jan 04 2021 | HSGX | Ocugen, Inc. | Tammara Vijay | Senior Vice Preside ... | Option Exercise | A | 1.83 | 220,500 | 403,515 | 220,500 | |
Jan 04 2021 | HSGX | Ocugen, Inc. | Kompella Uday | Director | Option Exercise | A | 1.83 | 126,000 | 230,580 | 126,000 | |
Jan 04 2021 | HSGX | Ocugen, Inc. | Taspolatoglu Suha | Director | Option Exercise | A | 1.83 | 126,000 | 230,580 | 126,000 | |
Jan 04 2021 | HSGX | Ocugen, Inc. | Musunuri Shankar | Chief Executive Off ... | Option Exercise | A | 1.83 | 1,757,000 | 3,215,310 | 1,757,000 | |
Jan 04 2021 | HSGX | Ocugen, Inc. | Subramanian Sanjay | Chief Financial Off ... | Option Exercise | A | 1.83 | 800,000 | 1,464,000 | 800,000 | |
Jan 04 2021 | HSGX | Ocugen, Inc. | Kumar Ramesh | Director | Option Exercise | A | 1.83 | 126,000 | 230,580 | 126,000 | |
Jan 04 2021 | HSGX | Ocugen, Inc. | Fernandes Prabhavathi | Director | Option Exercise | A | 1.83 | 126,000 | 230,580 | 126,000 | |
Jan 04 2021 | HSGX | Ocugen, Inc. | Potti Manish | Director | Option Exercise | A | 1.83 | 126,000 | 230,580 | 126,000 | |
Jan 04 2021 | HSGX | Ocugen, Inc. | Castillo Kirsten | Director | Option Exercise | A | 1.83 | 126,000 | 230,580 | 126,000 | |
Jan 04 2021 | HSGX | Ocugen, Inc. | Zhang Junge | Director | Option Exercise | A | 1.83 | 126,000 | 230,580 | 126,000 | |
Aug 17 2020 | HSGX | Ocugen, Inc. | Tammara Vijay | Senior Vice Preside ... | Option Exercise | A | 0.57 | 50,000 | 28,250 | 50,000 | |
May 29 2020 | HSGX | Ocugen, Inc. | Castillo Kirsten | Director | Buy | P | 0.31 | 75,000 | 23,498 | 75,000 | 0 to 75 K |
May 07 2020 | HSGX | Ocugen, Inc. | Musunuri Shankar | Chief Executive Off ... | Option Exercise | A | 0.33 | 1,357,145 | 447,858 | 1,357,145 | |
May 07 2020 | HSGX | Ocugen, Inc. | Subramanian Sanjay | Chief Financial Off ... | Option Exercise | A | 0.34 | 369,256 | 125,547 | 369,256 | |
May 07 2020 | HSGX | Ocugen, Inc. | Arumugham Rasappa | Chief Scientific Of ... | Option Exercise | A | 0.34 | 144,766 | 49,220 | 144,766 | |
May 07 2020 | HSGX | Ocugen, Inc. | JORGENSEN DANIEL | Chief Medical Offic ... | Option Exercise | A | 0.34 | 109,913 | 37,370 | 109,913 | |
May 07 2020 | HSGX | Ocugen, Inc. | Beck Kelly | Vice President | Option Exercise | A | 0.34 | 31,916 | 10,851 | 31,916 | |
May 07 2020 | HSGX | Ocugen, Inc. | Tammara Vijay | Senior Vice Preside ... | Option Exercise | A | 0.34 | 20,573 | 6,995 | 20,573 | |
Apr 08 2020 | HSGX | Ocugen, Inc. | Castillo Kirsten | Director | Option Exercise | A | 0.28 | 54,000 | 15,120 | 54,000 | |
Apr 08 2020 | HSGX | Ocugen, Inc. | Castillo Kirsten | Director | Option Exercise | A | 0.28 | 54,000 | 15,120 | 54,000 | |
Apr 08 2020 | HSGX | Ocugen, Inc. | Fernandes Prabhavathi | Director | Option Exercise | A | 0.28 | 54,000 | 15,120 | 54,000 | |
Apr 08 2020 | HSGX | Ocugen, Inc. | Fernandes Prabhavathi | Director | Option Exercise | A | 0.28 | 54,000 | 15,120 | 54,000 | |
Jan 03 2020 | HSGX | Ocugen, Inc. | Beck Kelly | Vice President | Option Exercise | A | 0.51 | 86,596 | 44,164 | 86,596 | |
Jan 03 2020 | HSGX | Ocugen, Inc. | Musunuri Shankar | Chief Executive Off ... | Option Exercise | A | 0.51 | 933,528 | 476,099 | 933,528 | |
Jan 03 2020 | HSGX | Ocugen, Inc. | JORGENSEN DANIEL | Chief Medical Offic ... | Option Exercise | A | 0.51 | 101,470 | 51,750 | 101,470 | |
Jan 03 2020 | HSGX | Ocugen, Inc. | Arumugham Rasappa | Chief Scientific Of ... | Option Exercise | A | 0.51 | 111,372 | 56,800 | 111,372 | |
Jan 03 2020 | HSGX | Ocugen, Inc. | Tammara Vijay | Vice President | Option Exercise | A | 0.51 | 77,641 | 39,597 | 77,641 | |
Jan 03 2020 | HSGX | Ocugen, Inc. | Subramanian Sanjay | Chief Financial Off ... | Option Exercise | A | 0.51 | 106,774 | 54,455 | 106,774 | |
Jan 03 2020 | HSGX | Ocugen, Inc. | Taspolatoglu Suha | Director | Option Exercise | A | 0.51 | 54,000 | 27,540 | 54,000 | |
Jan 03 2020 | HSGX | Ocugen, Inc. | Zhang Junge | Director | Option Exercise | A | 0.51 | 54,000 | 27,540 | 54,000 | |
Jan 03 2020 | HSGX | Ocugen, Inc. | Leo Frank | Director | Option Exercise | A | 0.51 | 54,000 | 27,540 | 54,000 | |
Jan 03 2020 | HSGX | Ocugen, Inc. | Potti Manish | Director | Option Exercise | A | 0.51 | 54,000 | 27,540 | 54,000 | |
Jan 03 2020 | HSGX | Ocugen, Inc. | Kompella Uday | Director | Option Exercise | A | 0.51 | 54,000 | 27,540 | 54,000 | |
Jan 03 2020 | HSGX | Ocugen, Inc. | Kumar Ramesh | Director | Option Exercise | A | 0.51 | 54,000 | 27,540 | 54,000 | |
Dec 13 2019 | HSGX | Ocugen, Inc. | Musunuri Shankar | Chief Executive Off ... | Buy | P | 0.35 | 143,000 | 50,050 | 406,000 | 263 K to 406 K (+54.37 %) |
Dec 13 2019 | HSGX | Ocugen, Inc. | Musunuri Shankar | Chief Executive Off ... | Buy | P | 0.35 | 143,000 | 50,050 | 406,000 | 263 K to 406 K (+54.37 %) |
Dec 13 2019 | HSGX | Ocugen, Inc. | Musunuri Shankar | Chief Executive Off ... | Buy | P | 0.41 | 263,000 | 107,830 | 263,000 | 0 to 263 K |
Dec 13 2019 | HSGX | Ocugen, Inc. | Musunuri Shankar | Chief Executive Off ... | Buy | P | 0.41 | 263,000 | 107,830 | 263,000 | 0 to 263 K |
Dec 05 2019 | HSGX | Ocugen, Inc. | Zhang Junge | Director | Buy | P | 0.44 | 220,000 | 96,800 | 818,578 | 598.6 K to 818.6 K (+36.75 %) |
Dec 02 2019 | HSGX | Ocugen, Inc. | Zhang Junge | Director | Buy | P | 0.37 | 270,000 | 99,900 | 600,078 | 330.1 K to 600.1 K (+81.80 %) |
Nov 26 2019 | HSGX | Ocugen, Inc. | Zhang Junge | Director | Buy | P | 0.27 | 115,000 | 31,050 | 330,078 | 215.1 K to 330.1 K (+53.47 %) |
Nov 26 2019 | HSGX | Ocugen, Inc. | Zhang Junge | Director | Buy | P | 0.28 | 80,000 | 22,400 | 215,078 | 135.1 K to 215.1 K (+59.23 %) |
Nov 26 2019 | HSGX | Ocugen, Inc. | Subramanian Sanjay | Chief Financial Off ... | Buy | P | 0.28 | 5,000 | 1,400 | 10,000 | 5 K to 10 K (+100.00 %) |
Nov 20 2019 | HSGX | Ocugen, Inc. | Zhang Junge | Director | Buy | P | 0.41 | 100,000 | 41,000 | 135,078 | 35.1 K to 135.1 K (+285.08 %) |
Oct 15 2019 | HSGX | Ocugen, Inc. | Zhang Junge | Director | Buy | P | 1.48 | 4,000 | 5,920 | 35,078 | 31.1 K to 35.1 K (+12.87 %) |
Oct 04 2019 | HSGX | Ocugen, Inc. | Subramanian Sanjay | Chief Financial Off ... | Option Exercise | A | 2.19 | 23,970 | 52,494 | 23,970 | |
Oct 04 2019 | HSGX | Ocugen, Inc. | Subramanian Sanjay | Chief Financial Off ... | Buy | P | 1.88 | 5,000 | 9,400 | 5,000 | 0 to 5 K |
Oct 04 2019 | HSGX | Ocugen, Inc. | Zhang Junge | Director | Buy | P | 2.95 | 2,000 | 5,900 | 31,078 | 29.1 K to 31.1 K (+6.88 %) |
Oct 04 2019 | HSGX | Ocugen, Inc. | Zhang Junge | Director | Buy | P | 3.30 | 3,000 | 9,900 | 29,078 | 26.1 K to 29.1 K (+11.50 %) |
Oct 04 2019 | HSGX | Ocugen, Inc. | Zhang Junge | Director | Buy | P | 3.35 | 5,000 | 16,750 | 26,078 | 21.1 K to 26.1 K (+23.72 %) |
Oct 04 2019 | HSGX | Ocugen, Inc. | Zhang Junge | Director | Buy | P | 3.80 | 2,000 | 7,600 | 21,078 | 19.1 K to 21.1 K (+10.48 %) |
Oct 04 2019 | HSGX | Ocugen, Inc. | Zhang Junge | Director | Buy | P | 3.10 | 1,163 | 3,605 | 19,078 | 17.9 K to 19.1 K (+6.49 %) |
Oct 04 2019 | HSGX | Ocugen, Inc. | Zhang Junge | Director | Buy | P | 3.35 | 2,000 | 6,700 | 17,915 | 15.9 K to 17.9 K (+12.57 %) |
Oct 04 2019 | HSGX | Ocugen, Inc. | Zhang Junge | Director | Buy | P | 3.10 | 10,000 | 31,000 | 15,915 | 5.9 K to 15.9 K (+169.06 %) |
Oct 04 2019 | HSGX | Ocugen, Inc. | Zhang Junge | Director | Buy | P | 2.62 | 200 | 524 | 5,915 | 5.7 K to 5.9 K (+3.50 %) |
Oct 04 2019 | HSGX | Ocugen, Inc. | Zhang Junge | Director | Buy | P | 2.49 | 200 | 498 | 5,715 | 5.5 K to 5.7 K (+3.63 %) |
Oct 04 2019 | HSGX | Ocugen, Inc. | Zhang Junge | Director | Buy | P | 2.50 | 660 | 1,650 | 5,515 | 4.9 K to 5.5 K (+13.59 %) |
Oct 04 2019 | HSGX | Ocugen, Inc. | Zhang Junge | Director | Buy | P | 2.48 | 3,000 | 7,440 | 4,855 | 1.9 K to 4.9 K (+161.73 %) |
Oct 04 2019 | HSGX | Ocugen, Inc. | Zhang Junge | Director | Buy | P | 2.45 | 100 | 245 | 1,855 | 1.8 K to 1.9 K (+5.70 %) |
Oct 04 2019 | HSGX | Ocugen, Inc. | Zhang Junge | Director | Buy | P | 2.47 | 1,358 | 3,354 | 1,755 | 397 to 1.8 K (+342.07 %) |
Oct 04 2019 | HSGX | Ocugen, Inc. | Zhang Junge | Director | Buy | P | 2.46 | 200 | 492 | 397 | 197 to 397 (+101.52 %) |
Oct 04 2019 | HSGX | Ocugen, Inc. | Zhang Junge | Director | Buy | P | 2.45 | 197 | 483 | 197 | 0 to 197 |
Feb 11 2019 | HSGX | HISTOGENICS CORP | Wilmslow Estates Ltd | 10% Owner | Option Exercise | M | 0.01 | 1,244,444 | 12,444 | 0 | |
Feb 11 2019 | HSGX | HISTOGENICS CORP | Wilmslow Estates Ltd | 10% Owner | Option Exercise | M | 0.01 | 403,845 | 4,038 | 0 | |
Feb 11 2019 | HSGX | HISTOGENICS CORP | Wilmslow Estates Ltd | 10% Owner | Buy | M | 0.00 | 1,244,444 | 0 | 5,258,859 | 4 M to 5.3 M (+31.00 %) |
Feb 11 2019 | HSGX | HISTOGENICS CORP | Wilmslow Estates Ltd | 10% Owner | Buy | M | 0.00 | 403,845 | 0 | 4,014,415 | 3.6 M to 4 M (+11.19 %) |
Feb 11 2019 | HSGX | HISTOGENICS CORP | Lewis Michael | Director | Option Exercise | M | 0.01 | 1,244,444 | 12,444 | 0 | |
Feb 11 2019 | HSGX | HISTOGENICS CORP | Lewis Michael | Director | Option Exercise | M | 0.01 | 403,845 | 4,038 | 0 | |
Feb 11 2019 | HSGX | HISTOGENICS CORP | Lewis Michael | Director | Buy | M | 0.00 | 1,244,444 | 0 | 5,258,859 | 4 M to 5.3 M (+31.00 %) |
Feb 11 2019 | HSGX | HISTOGENICS CORP | Lewis Michael | Director | Buy | M | 0.00 | 403,845 | 0 | 4,014,415 | 3.6 M to 4 M (+11.19 %) |
Feb 11 2019 | HSGX | HISTOGENICS CORP | RAKIN KEVIN | Director | Option Exercise | M | 0.01 | 111,111 | 1,111 | 0 | |
Feb 11 2019 | HSGX | HISTOGENICS CORP | RAKIN KEVIN | Director | Option Exercise | M | 0.01 | 33,333 | 333 | 0 | |
Feb 11 2019 | HSGX | HISTOGENICS CORP | RAKIN KEVIN | Director | Option Exercise | M | 0.01 | 33,333 | 333 | 0 | |
Feb 11 2019 | HSGX | HISTOGENICS CORP | RAKIN KEVIN | Director | Option Exercise | M | 0.01 | 173,076 | 1,731 | 0 | |
Feb 11 2019 | HSGX | HISTOGENICS CORP | RAKIN KEVIN | Director | Buy | M | 0.00 | 111,111 | 0 | 257,846 | 146.7 K to 257.8 K (+75.72 %) |
Feb 11 2019 | HSGX | HISTOGENICS CORP | RAKIN KEVIN | Director | Buy | M | 0.00 | 33,333 | 0 | 66,666 | 33.3 K to 66.7 K (+100.00 %) |
Feb 11 2019 | HSGX | HISTOGENICS CORP | RAKIN KEVIN | Director | Buy | M | 0.00 | 33,333 | 0 | 66,666 | 33.3 K to 66.7 K (+100.00 %) |
Feb 11 2019 | HSGX | HISTOGENICS CORP | RAKIN KEVIN | Director | Buy | M | 0.00 | 173,076 | 0 | 418,639 | 245.6 K to 418.6 K (+70.48 %) |
Jan 15 2019 | HSGX | HISTOGENICS CORP | KIRK RANDAL J | 10% Owner | Sell | S | 0.15 | 345,897 | 51,885 | 1,692,366 | 2 M to 1.7 M (-16.97 %) |
Jan 15 2019 | HSGX | HISTOGENICS CORP | KIRK RANDAL J | 10% Owner | Sell | S | 0.16 | 400,507 | 64,081 | 2,038,263 | 2.4 M to 2 M (-16.42 %) |
Jan 15 2019 | HSGX | HISTOGENICS CORP | KIRK RANDAL J | 10% Owner | Sell | S | 0.17 | 251,800 | 42,806 | 2,438,770 | 2.7 M to 2.4 M (-9.36 %) |
Oct 11 2018 | HSGX | HISTOGENICS CORP | RAKIN KEVIN | Director | Option Exercise | P | 0.70 | 173,076 | 121,153 | 173,076 | |
Oct 11 2018 | HSGX | HISTOGENICS CORP | RAKIN KEVIN | Director | Buy | P | 0.00 | 230,768 | 0 | 245,563 | 14.8 K to 245.6 K (+1,559.77 %) |
Oct 11 2018 | HSGX | HISTOGENICS CORP | Wilmslow Estates Ltd | 10% Owner | Option Exercise | P | 0.70 | 403,845 | 282,692 | 403,845 | |
Oct 11 2018 | HSGX | HISTOGENICS CORP | Wilmslow Estates Ltd | 10% Owner | Buy | P | 0.00 | 538,460 | 0 | 3,610,570 | 3.1 M to 3.6 M (+17.53 %) |
Oct 11 2018 | HSGX | HISTOGENICS CORP | Lewis Michael | Director | Option Exercise | P | 0.70 | 403,845 | 282,692 | 403,845 | |
Oct 11 2018 | HSGX | HISTOGENICS CORP | Lewis Michael | Director | Buy | P | 0.00 | 538,460 | 0 | 3,610,570 | 3.1 M to 3.6 M (+17.53 %) |
Oct 03 2018 | HSGX | HISTOGENICS CORP | Kennedy Stephen Richard | Chief Operating Off ... | Option Exercise | D | 9.96 | 30,000 | 298,800 | 0 | |
Oct 03 2018 | HSGX | HISTOGENICS CORP | Kennedy Stephen Richard | Chief Operating Off ... | Option Exercise | A | 0.57 | 115,000 | 65,320 | 115,000 | |
Oct 03 2018 | HSGX | HISTOGENICS CORP | Kennedy Stephen Richard | Chief Operating Off ... | Option Exercise | D | 2.63 | 115,000 | 302,450 | 0 | |
Oct 03 2018 | HSGX | HISTOGENICS CORP | Kennedy Stephen Richard | Chief Operating Off ... | Option Exercise | A | 0.57 | 50,000 | 28,400 | 50,000 | |
Oct 03 2018 | HSGX | HISTOGENICS CORP | Kennedy Stephen Richard | Chief Operating Off ... | Option Exercise | D | 2.12 | 50,000 | 106,000 | 0 | |
Oct 03 2018 | HSGX | HISTOGENICS CORP | Kennedy Stephen Richard | Chief Operating Off ... | Option Exercise | A | 0.57 | 75,000 | 42,600 | 75,000 | |
Oct 03 2018 | HSGX | HISTOGENICS CORP | Kennedy Stephen Richard | Chief Operating Off ... | Option Exercise | D | 1.72 | 75,000 | 129,000 | 0 |